Plazomicin
Based on 1 publication(s) in Google Scholar
Plazomicin (ACHN 490) is a semi-synthetic aminoglycoside Antibiotic. Plazomicin acts as a substrate for Aminoglycoside acetyltransferase and Aminoglycoside phosphotransferase. Plazomicin is not modified by various common aminoglycoside-modifying enzymes. Plazomicin selectively inhibits MATE2-K. Plazomicin exhibits activity against multidrug-resistant bacteria, including carbapenem-resistant Enterobacterales.
The free form of the compound is prone to instability, it is advisable to consider the stable salt form (Plazomicin sulfate) that retains the same biological activity.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1154757-24-0
- Formule: C25H48N6O10
- Masse moléculaire:592.68
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Plazomicin
MoreVoir tous les produits spécifiques à Isoform Antibiotic
More
Activité biologique
Description
In Vitro
Plazomicin exhibits MIC50/90 = 0.25-0.5 μg/mL/0.5-1 μg/mL Against Klebsiella, Escherichia, Enterobacter, Serratia, and Citrobacter species[1].
Plazomicin selectively inhibits MATE2-K and to a lesser extent MATE1, and OCT2, which are important transporters involved with tubular secretion[1].
Plazomicin (18 h) retains antibacterial activity against most aminoglycoside modifying enzyme-expressing E. coli BW25113 and E. coli BW25113 ΔbamB ΔtolC strains[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1154757-24-0
-
Masse moléculaire 592.68
-
Formule C25H48N6O10
-
SMILES
O[C@H]([C@H]([C@@](C)(O)CO1)NC)[C@@]1([H])O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@@]3([H])OC(CNCCO)=CC[C@H]3N)[C@@H]2O)NC([C@@H](O)CCN)=O
-
Synonyms
ACHN 490
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Pureté et documentation
Références
[1]. Clark JA, et al. Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance. Ther Adv Infect Dis. 2020;7:2049936120952604. Published 2020 Sep 4. [Content Brief]
[2]. Cox G, et al. Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes. ACS Infect Dis. 2018;4(6):980-987. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Plazomicin
- 1154757-24-0
- ACHN 490
- ACHN490
- ACHN-490
- Antibiotic
- Bacterial
- complicated urinary tract infections
- MATE2-K
- nephrotoxicity
- 16S rRNA ribosomal methyltransferases
- acute pyelonephritis
- carbapenem-resistant Enterobacteriaceae
- aminoglycoside acetyltransferase AAC(2')-Ia
- aminoglycoside phosphotransferase APH(2'')-IVa
- ototoxicity
- Escherichia coli
- Inhibitor
- inhibitor
- inhibit